Retinal Physician

06/13/2026

Amazing meeting going on in Las Vegas! Look for our coverage of Clinical Trials at the Summit next week.

06/11/2026

We're excited to partner with OIS Retina on July 14 in Montreal. With innovative companies presenting, expert panels, and unmatched networking, this is a retina event you won't want to miss. Learn more and register today.
https://ois.net/retina-innovation-summit-register/

06/09/2026

Reflecting on Retina World Congress 2026 👁️

In this video snippet, Ashkan M. Abbey, MD, reviews the evolving Duravyu (EYP-1901) clinical program from EyePoint Pharmaceuticals, including the upcoming pivotal phase 3 milestones in wet AMD.

With top-line data from the LUGANO and LUCIA trials expected later this year, the retina field is watching closely.

Watch the full video below 👇
https://ow.ly/2GBQ50Z53H9

06/08/2026

Arshad M. Khanani, MD, previews this year's Clinical Trials at the Summit meeting in Las Vegas, including first presentations of phase 2 and phase 3 clinical trial data, expert panel discussions on a variety of topics, and a keynote lecture from former FDA ophthalmic devices division director Wiley A. Chambers, MD.

https://www.retinalphysician.com/issues/2026/clinical-trials-at-the-summit/cts-2026-preview/

06/04/2026

Your eyes might be trying to tell you more than you think 👀

At Retina World Congress, Katherine E. Talcott, MD, FASRS, shared research linking BRVO and CRVO with increased risks of stroke, heart attack, and carotid disease, highlighting how retinal findings may reveal important clues about systemic health.

Read more: https://ow.ly/lTb050Z2AcK

06/02/2026

🌍 Can telemedicine help close the gap in retinal care?

In a new article, Nnamdi Elem Okore, OD, explores how teleretinal screening, AI-assisted imaging, and remote monitoring are improving access to diabetic retinopathy care for underserved communities 👁️

From equity and efficiency to the future of AI-driven screening, the article examines how telemedicine is reshaping retina care worldwide.

Read more: https://ow.ly/xmIG50Z0c6Y

https://res.cloudinary.com/broadcastmed/image/fetch/e_unsharp_mask:70,q_auto,c_fill,f_auto,w_170,h_230/dpr_auto/https://retinalphysician.com/media/4tbpmbe0/010926-omd-web-covers-staff.jpg

06/01/2026

Can dual-pathway gene therapy improve outcomes in retinal disease? 👁️

In this video snippet from ARVO 2026, Katie Binley, PhD, CSO of Ikarovec, discusses the company’s bicistronic gene therapy platform designed to combine neuroprotection and complement modulation for geographic atrophy and other retinal diseases.

Watch the full clip below 👇
https://ow.ly/KBNg50Z53zr

05/29/2026

📍 Retina World Congress 2026

Retina specialists say durability is still the biggest unmet need in wet AMD treatment.

David A. Eichenbaum, MD, explored emerging phase 3 gene therapy data showing sustained protein expression, reduced supplemental injections, and encouraging long-term results in nAMD.

“It’s exciting because there’s a lot of directional evidence that we now have durable protein production and durable clinical effect with these drugs.”

Read more: https://ow.ly/GPzv50Z1vhR

05/27/2026

How are big data and AI reshaping ophthalmology research?

At the 2026 Cogan Award Lecture at , Cecilia S. Lee, MD, MS, and Aaron Y. Lee, MD, MSCI, explored the evolution from paper charts to AI-driven precision health, and the mentors and collaborations that shaped their journey.

Read more 👇
https://ow.ly/cqMf50Z2zBi

05/26/2026